Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8947 |
High Similarity |
NPD6559 |
Discontinued |
0.8683 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8663 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8589 |
High Similarity |
NPD920 |
Approved |
0.8503 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8466 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8284 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8239 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8198 |
Intermediate Similarity |
NPD919 |
Approved |
0.8192 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8192 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8166 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.816 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8156 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8101 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8045 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8035 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8023 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7978 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7966 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7919 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7861 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7841 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7824 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7816 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7814 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7814 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7811 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7803 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7791 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7735 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7711 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7711 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7667 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7667 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7653 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7624 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7563 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7556 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7554 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7525 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7513 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2532 |
Approved |
0.75 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2534 |
Approved |
0.75 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2533 |
Approved |
0.75 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7471 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7461 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD1511 |
Approved |
0.744 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7418 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7401 |
Intermediate Similarity |
NPD37 |
Approved |
0.7391 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7381 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7374 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7374 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7374 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7366 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7363 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7363 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7356 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7351 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6776 |
Approved |
0.733 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7323 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7323 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7323 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7322 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7305 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7293 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7286 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7264 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7251 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD7240 |
Approved |
0.722 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7209 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD1933 |
Approved |
0.72 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7196 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7174 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7167 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7167 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7157 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7157 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7157 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.715 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7069 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7018 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7014 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.6995 |
Remote Similarity |
NPD7999 |
Approved |
0.6988 |
Remote Similarity |
NPD2798 |
Approved |
0.6977 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6963 |
Remote Similarity |
NPD6764 |
Approved |
0.6963 |
Remote Similarity |
NPD6765 |
Approved |
0.6951 |
Remote Similarity |
NPD9717 |
Approved |
0.6944 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD1203 |
Approved |
0.6923 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6919 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6915 |
Remote Similarity |
NPD2403 |
Approved |
0.6915 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6901 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6893 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.689 |
Remote Similarity |
NPD1091 |
Approved |
0.689 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6869 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD5889 |
Approved |
0.6868 |
Remote Similarity |
NPD5890 |
Approved |
0.6845 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6842 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6842 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6836 |
Remote Similarity |
NPD6190 |
Approved |
0.6831 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6826 |
Remote Similarity |
NPD3267 |
Approved |
0.6826 |
Remote Similarity |
NPD2797 |
Approved |
0.6826 |
Remote Similarity |
NPD3266 |
Approved |
0.6821 |
Remote Similarity |
NPD6784 |
Approved |
0.6821
|
Remote Similarity |
NPD6785 |
Approved |